Tag Archives: Gastro-esophageal Junction Cancer
A New Treatment Option for patients with Gastric Cancer
Gastric cancer is the fourth most commonly diagnosed cancer and the second most common cause of cancer-related deaths worldwide. Previous study has found that patients with operable disease have a 5-year survival rate of 36%. In patients with advanced or … Continue reading
Posted in Cancer, Gastric Cancer
Tagged 5-Fluorouracil, capecitabine, chemotherapy, Cisplatin, Gastric Cancer, Gastro-esophageal Junction Cancer, Herceptin, Survival, Trastuzumab, Xeloda
Comments Off on A New Treatment Option for patients with Gastric Cancer